| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 11829* | 2021 |
| Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes L Zhu, ZG She, X Cheng, JJ Qin, XJ Zhang, J Cai, F Lei, H Wang, J Xie, ... Cell metabolism 31 (6), 1068-1077. e3, 2020 | 1489 | 2020 |
| Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with … P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie, YM Liu, YC Zhao, X Huang, ... Circulation research 126 (12), 1671-1681, 2020 | 1169 | 2020 |
| In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19 XJ Zhang, JJ Qin, XU Cheng, L Shen, YC Zhao, Y Yuan, F Lei, MM Chen, ... Cell metabolism 32 (2), 176-187. e4, 2020 | 434 | 2020 |
| Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease Z Chen, R Tian, Z She, J Cai, H Li Free Radical Biology and Medicine 152, 116-141, 2020 | 407 | 2020 |
| Longitudinal association between markers of liver injury and mortality in COVID‐19 in China F Lei, YM Liu, F Zhou, JJ Qin, P Zhang, L Zhu, XJ Zhang, J Cai, L Lin, ... Hepatology 72 (2), 389-398, 2020 | 384 | 2020 |
| Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta‐analysis F Zhou, J Zhou, W Wang, XJ Zhang, YX Ji, P Zhang, ZG She, L Zhu, J Cai, ... Hepatology 70 (4), 1119-1133, 2019 | 353 | 2019 |
| Epidemiological features of NAFLD from 1999 to 2018 in China J Zhou, F Zhou, W Wang, XJ Zhang, YX Ji, P Zhang, ZG She, L Zhu, J Cai, ... Hepatology 71 (5), 1851-1864, 2020 | 250 | 2020 |
| Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice JH Zhou, JJ Cai, ZG She, HL Li World journal of gastroenterology 25 (11), 1307, 2019 | 163 | 2019 |
| MicroRNA miR-27b rescues bone marrow–derived angiogenic cell function and accelerates wound healing in type 2 diabetes mellitus JM Wang, J Tao, DD Chen, JJ Cai, K Irani, Q Wang, H Yuan, AF Chen Arteriosclerosis, thrombosis, and vascular biology 34 (1), 99-109, 2014 | 152 | 2014 |
| Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19 JJ Qin, X Cheng, F Zhou, F Lei, G Akolkar, J Cai, XJ Zhang, A Blet, J Xie, ... Hypertension 76 (4), 1104-1112, 2020 | 145 | 2020 |
| Insights into the epidemiology, pathogenesis, and therapeutics of nonalcoholic fatty liver diseases Y Yu, J Cai, Z She, H Li Advanced Science 6 (4), 1801585, 2019 | 130 | 2019 |
| Impact of miRNA in atherosclerosis Y Lu, T Thavarajah, W Gu, J Cai, Q Xu Arteriosclerosis, thrombosis, and vascular biology 38 (9), e159-e170, 2018 | 129 | 2018 |
| Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and pre-existing type 2 diabetes X Cheng, YM Liu, H Li, X Zhang, F Lei, JJ Qin, Z Chen, KQ Deng, L Lin, ... Cell metabolism 32 (4), 537-547. e3, 2020 | 126 | 2020 |
| Perioperative presentation of COVID‐19 disease in a liver transplant recipient J Qin, H Wang, X Qin, P Zhang, L Zhu, J Cai, Y Yuan, H Li Hepatology 72 (4), 1491-1493, 2020 | 125 | 2020 |
| The role of innate immune cells in nonalcoholic steatohepatitis J Cai, XJ Zhang, H Li Hepatology 70 (3), 1026-1037, 2019 | 121 | 2019 |
| Nonalcoholic fatty liver disease: an emerging driver of hypertension YC Zhao, GJ Zhao, Z Chen, ZG She, J Cai, H Li Hypertension 75 (2), 275-284, 2020 | 106 | 2020 |
| Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis P Xu, B Wang, Y Lu, QY Wu, ML Zhou, JR Wu, JJ Cai, X Sun, H Yuan bmj 365, 2019 | 105 | 2019 |
| Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases J Cai, XJ Zhang, YX Ji, P Zhang, ZG She, H Li Circulation research 126 (5), 679-704, 2020 | 103 | 2020 |
| Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism J Cai, Y Hong, C Weng, C Tan, J Imperato-McGinley, YS Zhu American Journal of Physiology-Heart and Circulatory Physiology 300 (4 …, 2011 | 98 | 2011 |
Timothy BilliarUniversity of Pittsburgh在 upmc.edu 的电子邮件经过验证
